Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Beacon Pharmaceuticals Limited, DCC Vital, Westminster Industrial Estate, Repton Road, Measham, DE12 7DT, England
Colistimethate Sodium 1 Million I.U. Powder for Solution for Injection.
| Pharmaceutical Form |
|---|
|
Powder for Solution for Injection. White lyophilised powder in a glass vial. |
Colistimethate Sodium 1 Million I.U. (International Units).
| Active Ingredient | Description | |
|---|---|---|
| Colistimethate |
Colistimethate is a cyclic polypeptide antibacterial active substance that is derived from Bacillus polymyxa var colistinus and belongs to the polymyxin group. Polymyxins work by damaging the cell membrane and the resulting physiological effects are lethal to the bacterium. Polymyxins are selective for Gram-negative bacteria that have a hydrophobic outer membrane. |
| List of Excipients |
|---|
|
None. |
7 ml Type I glass vial with a rubber stopper and an aluminium cap. Each carton contains 1 or 10 vials.
Beacon Pharmaceuticals Limited, DCC Vital, Westminster Industrial Estate, Repton Road, Measham, DE12 7DT, England
PL 18157/0009
16/05/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
